Not Yet Recruiting
Downstaging Prediction Model for HCC
NCT07058649
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Clinical trial condition
Liver Neoplasms
Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.
1,743 public trials
464 recruiting studies
Liver Neoplasms trial results
Not Yet Recruiting
LTFU for All Cell and Gene Therapy Studies
NCT06194461
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +18 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Duarte, California, United States
- Research Site Orange, California, United States
- Research Site San Francisco, California, United States
Not Yet Recruiting
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
NCT07038863
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +29 more
- Locations
-
- Centre Hospitalier Annecy Genevois Annecy, France
- Centre Expert Hépatites Virales Aquitaine, CHU de Bordeaux Bordeaux, France
- CHU de Clermont Ferrand Clermont-Ferrand, France
- Hôpital Henri Mondor - Assistante Publique Hopitaux de Paris (APHP) Créteil, France
Not Yet Recruiting
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
NCT07027436
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Juravinski Hospital Hamilton, Ontario, Canada
Not Yet Recruiting
Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence
NCT06954116
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
NCT07010588
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Army Medical University Chongqing, Chongqing Municipality, China
- Handan Central Hospital Handan, Hebei, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
Not Yet Recruiting
Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer
NCT06999512
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +18 more
- Locations
-
- CHU Estaing Clermont-Ferrand, France
- Hôpital Bicêtre Le Kremlin-Bicêtre, France
- Chru Lille - Hopital Huriez Lille, France
- Hôpital Croix Rousse, HCL Lyon, France
Not Yet Recruiting
Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma
NCT06994572
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not Yet Recruiting
TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC
NCT06990620
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
NCT06984718
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
Not specified